A drug with the SMILES CC(C)C[C@H](NC(=O)c1nc[nH]c1C(=O)NCc1ccc(CNC(=O)OC(C)(C)C)cc1)C(=O)OC(C)(C)C has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 10.634\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(C)C[C@H](NC(=O)c1nc[nH]c1C(=O)NCc1ccc(CNC(=O)OC(C)(C)C)cc1)C(=O)OC(C)(C)C
CC(C)C[C@H](NC(=O)c1nc[nH]c1C(=O)NCc1ccc(CNC(=O)OC(C)(C)C)cc1)C(=O)OC(C)(C)C
tert-butyl (2S)-4-methyl-2-[[5-[[4-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]phenyl]methylcarbamoyl]-1H-imidazole-4-carbonyl]amino]pentanoate